1. Home
  2. LFVN vs NSRX Comparison

LFVN vs NSRX Comparison

Compare LFVN & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifevantage Corporation (Delaware)

LFVN

Lifevantage Corporation (Delaware)

HOLD

Current Price

$4.40

Market Cap

54.9M

Sector

Health Care

ML Signal

HOLD

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$2.01

Market Cap

53.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LFVN
NSRX
Founded
N/A
2019
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.9M
53.5M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
LFVN
NSRX
Price
$4.40
$2.01
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$19.67
AVG Volume (30 Days)
97.6K
160.9K
Earning Date
05-05-2026
03-20-2026
Dividend Yield
4.19%
N/A
EPS Growth
226.09
N/A
EPS
0.19
N/A
Revenue
$203,204,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$22.63
N/A
Revenue Growth
1.86
N/A
52 Week Low
$3.90
$2.14
52 Week High
$16.14
$9.99

Technical Indicators

Market Signals
Indicator
LFVN
NSRX
Relative Strength Index (RSI) 38.05 25.92
Support Level $4.32 N/A
Resistance Level $5.37 $5.20
Average True Range (ATR) 0.29 0.32
MACD -0.04 -0.08
Stochastic Oscillator 23.70 0.00

Price Performance

Historical Comparison
LFVN
NSRX

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: